Advanced Pharmaceutical Bulletin
ISSN 2228-5881 · Tabriz University of Medical Sciences · Iran · active 2012–2026
Metrics
- Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 1.6
- SJR
- 0.795
- h-index
- 65
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 15 November 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Advanced Pharmaceutical Bulletin is Q1 in all 2 of its subject categories.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | Q1 | #21 of 131 |
| Pharmaceutical Science | Q1 | #49 of 195 |
- Cites per document (2 years, Scopus)
- 4.65
- Documents indexed in 2025 (Scopus)
- 82
OpenAlex counts about 1.6 citations per paper over two years; Scopus, through Scimago, counts 4.65 per document. The two databases index different journals, documents and citations, so the figures differ. Neither is a Clarivate Journal Impact Factor.
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Advanced Pharmaceutical Bulletin is Q1 in all 2 of its Scimago subject categories (2025 edition; best category Pharmacology, Toxicology and Pharmaceutics (miscellaneous): Q1, #21 of 131), with SJR 0.795 (Scimago) and an h-index of 65 (OpenAlex). Listed in DOAJ, Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Responding time
- Submission to publication
- ~12 wkDOAJ self-reported
Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.
Indexing & access
- Indexed in
- DOAJScopusWeb of SciencePubMed
- Access status:
- gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
- Article processing charge
- Free to publish — DOAJ lists no article processing charge (APC).
Scope
Frequently asked
Is Advanced Pharmaceutical Bulletin a predatory journal?
Our screening does not flag Advanced Pharmaceutical Bulletin. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Advanced Pharmaceutical Bulletin indexed in Scopus or Web of Science?
Per our venue index, Advanced Pharmaceutical Bulletin appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Advanced Pharmaceutical Bulletin?
Papers in Advanced Pharmaceutical Bulletin are cited about 1.6 times each within two years of publication, and Scimago places it in Q1, with an h-index of 65. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Advanced Pharmaceutical Bulletin (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Advanced Pharmaceutical Bulletin is Q1 in all 2 of its subject categories. By category: Pharmacology, Toxicology and Pharmaceutics (miscellaneous): Q1, #21 of 131; Pharmaceutical Science: Q1, #49 of 195. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Advanced Pharmaceutical Bulletin is cited about 1.6 times per paper over two years, with an h-index of 65.
What is the Web of Science (JCR) quartile of Advanced Pharmaceutical Bulletin?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Advanced Pharmaceutical Bulletin. The open equivalent is its Scimago quartile, Q1, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Advanced Pharmaceutical Bulletin open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Is Advanced Pharmaceutical Bulletin free to publish in?
Free to publish — DOAJ lists no article processing charge (APC). So there is no fee for authors to publish in Advanced Pharmaceutical Bulletin. Fee policies change — confirm on the journal's own site before relying on it.
How long does Advanced Pharmaceutical Bulletin take to publish a paper?
Submission to publication for Advanced Pharmaceutical Bulletin takes about ~12 wk — DOAJ self-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Advanced Pharmaceutical Bulletin.
Ready to submit? Tools for your next paper
Similar venues
- Journal of Pharmaceutical SciencesQ2 · Elsevier BV
- Biological and Pharmaceutical BulletinQ2 · Pharmaceutical Society of Japan
- Indian Journal of Pharmaceutical Education and ResearchQ3 · Association of Pharmaceutical Teachers of India
- International Journal of Applied PharmaceuticsQ3 · Innovare Academic Sciences
- Journal of Fluorine ChemistryQ3 · Elsevier BV
- Die PharmazieQ3 · Avoxa
Compare it with its peers: Ranked Medicine journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.